The renin–angiotensin–aldosterone system often affects the regulation of such precursors, with renin increasing in patients with hyperkalaemia, and mineralocorticoid receptor antagonist (MRA) antihypertensives and spironolactone needing to be paused before testing for renin function. The gene discussed is REN; the disease is Hyperkalemia.